EX-4.2
from 8-K
104 pages
Pfizer Investment Enterprises Pte. Ltd., as Issuer Pfizer Inc., as Parent Guarantor and the Bank of New York Mellon, as Trustee First Supplemental Indenture Dated as of May 19, 2023 to Indenture Dated as of May 19, 2023 4.650% Notes Due 2025 4.450% Notes Due 2026 4.450% Notes Due 2028 4.650% Notes Due 2030 4.750% Notes Due 2033 5.110% Notes Due 2043 5.300% Notes Due 2053 5.340% Notes Due 2063
12/34/56
EX-4.2
from 8-K
42 pages
Pfizer Inc. and the Bank of New York Mellon, as Trustee the Bank of New York Mellon, London Branch as Paying Agent Tenth Supplemental Indenture Dated as of December 19, 2017 to Indenture Dated as of January 30, 2001 £1,375,882,000 2.735 Per Cent. Notes Due 2043
12/34/56
EX-4.2
from 8-K
62 pages
Pfizer Inc. and the Bank of New York Mellon, Trustee the Bank of New York Mellon, London Branch, Paying Agent and Calculation Agent Ninth Supplemental Indenture Dated as of March 6, 2017 to Indenture Dated as of January 30, 2001 Floating Rate Notes Due 2019 0.000% Notes Due 2020 0.250% Notes Due 2022 1.000% Notes Due 2027
12/34/56
EX-4.2
from 8-A12B
62 pages
Pfizer Inc. and the Bank of New York Mellon, Trustee the Bank of New York Mellon, London Branch, Paying Agent and Calculation Agent Ninth Supplemental Indenture Dated as of March 6, 2017 to Indenture Dated as of January 30, 2001 Floating Rate Notes Due 2019 0.000% Notes Due 2020 0.250% Notes Due 2022 1.000% Notes Due 2027
12/34/56